Healthy people should not take aspirin to ward off heart attack research shows

By Rebecca Smith, Medical Editor Published: 8:30AM GMT 03 March 2010

Aspirin has been hailed as a "wonder" drug that can provide conditions identical to Alzheimer?s and diabetes and could potentially even forestall a little forms of cancer

Millions of people take a low sip of aspirin daily, as it is well known to revoke the risk of carrying a heart conflict or cadence in people who have already had one attack.

It is seen as a "just in case" magnitude and, since aspirin has been accessible for around 100 years, it is deliberate protected by the infancy of people.

Common painkillers "increase risk of conference loss" Aspirin can "boost breast cancer survival" Popular painkiller might revoke Parkinson"s How smashing are "wonder" drugs? Healthy people "should not take aspirin to forestall heart attack" Aspirin "can forestall hereditary form of bowel cancer"

However, aspirin increases the odds of vital bleeding, in the brain, go through or elsewhere in the body, and experts warned that the profitable goods contingency be weighed opposite the risk of harm.

Aspirin, that thins the blood, has been hailed as a consternation drug since it is far-reaching range of uses together with shortening the risk of a second heart conflict or stroke, augmenting justification that it might forestall a little cancers and might have an affect on dementia.

Research carried out in Scotland and published in the Journal of the American Medical Association found that aspirin taken by people who have no external symptoms of heart disease did not revoke the risk of a heart conflict when compared to those on a manikin pill.

Those on aspirin were at roughly twice the risk of pang a bleed, nonetheless the altogether risk was small, the investigate found.

Professor Peter Weissberg, Medical Director of the British Heart Foundation, said: "We know that a small every day sip of aspirin can revoke the risk of a heart conflict in people with angina and in those whove had a heart attack. In these cases, this intensity good outweighs the risk of inner bleeding, that is a side outcome of aspirin.

"This investigate sought to settle if people with justification of red blood vessel disease in their legs that raises the risk of carrying a heart conflict in destiny would additionally good from receiving every day aspirin.

"The formula show that these people dont good any heart-protective good from receiving a every day sip of aspirin and were some-more disposed to inner draining complications than people who took a placebo.

"The commentary determine with the stream recommendation that people who do not have symptomatic or diagnosed red blood vessel or heart disease should not take aspirin, since the risks of draining might transcend the benefits."

The hearing concerned roughly 30,000 men and women elderly in in between 50 and 75 who had not been diagnosed with heart disease.

A dimensions was taken of the red blood vigour in the ankle compared with the arm that is taken as a pointer of disease in the extremities that can be an early notice vigilance of heart problems in the future.

The with a low comparative measure were incidentally reserved to embrace 100mg of aspirin every day or a manikin drug.

After eight years there was no disproportion in the rate of heart conflict or stoke in in between the groups.

Lead writer Prof Gerry Fowkes of the Wolfson Unit for Prevention of Peripheral Vascular Disease in Edinburgh additionally found that there were 34 vital bleeds in people receiving aspirin, or dual per cent, compared with twenty or 1.2 per cent of those on the remedy and this was not deliberate statistically significant.

Prof Fowkes pronounced the low ankle brachial exam did not brand patients that would good from aspirin but pronounced since it is poor and easy to lift out and does settle people at risk of destiny heart problems it could still be used as a screening test.

In an concomitant paper Dr Jeffrey Berger, of the New York University School of Medicine, wrote: "The hearing supports commentary of a new meta-analysis that unsuccessful to denote a good of aspirin care for patients with extrinsic red blood vessel disease.

"Based on the hearing conducted by Fowkes et al and alternative identical studies, aspirin appears to have extrinsic benefits for shortening primary cardiovascular events when used for patients but clinically clear cardiovascular disease and is compared with higher rates of draining events in these patients. Nevertheless, aspirin stays an in effect healing representative for delegate impediment of cardiovascular events."

A orator for the Aspirin Foundation said: "We are in the routine of drafting a full reply to this paper.

"The subjects were a small organisation of a younger age than, for e.g. in the Womans Health study. It lacked interpretation and appeared that even the authors put in caveats about the significance. Thus it is innapropiate to contend that Aspirin was not useful.

"The ABI process for last bearing for diagnosis released the all critical alternative factors - obesity, lifestyle and family story that are some-more manly guides to cardiovascular risk."